Are you over 18 and want to see adult content?
More Annotations
![A complete backup of palermocalcio.it](https://www.archivebay.com/archive/ae279500-0fdc-47d5-9761-0abc99788758.png)
A complete backup of palermocalcio.it
Are you over 18 and want to see adult content?
![A complete backup of ilcanticodellanatura.it](https://www.archivebay.com/archive/c22a684e-080e-4a1c-ab84-9ac11daaec56.png)
A complete backup of ilcanticodellanatura.it
Are you over 18 and want to see adult content?
![A complete backup of racedirectorshq.com](https://www.archivebay.com/archive/ea474684-32df-4424-8f03-02b67ff0511a.png)
A complete backup of racedirectorshq.com
Are you over 18 and want to see adult content?
![A complete backup of climbingvinescafe.com](https://www.archivebay.com/archive/aa4682e4-049d-4299-bec9-062731c4247b.png)
A complete backup of climbingvinescafe.com
Are you over 18 and want to see adult content?
![A complete backup of incense-incense.com](https://www.archivebay.com/archive/ef7b2bde-28c4-4636-b41a-b9d543cdf60a.png)
A complete backup of incense-incense.com
Are you over 18 and want to see adult content?
![A complete backup of bqinvesttraining.com](https://www.archivebay.com/archive/77e6728c-a16b-4d82-869a-d9cd49f8ffd0.png)
A complete backup of bqinvesttraining.com
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of toskov-yordanov.com](https://www.archivebay.com/archive2/3fc3f95f-0c97-4dcd-b4ff-d520c5c879da.png)
A complete backup of toskov-yordanov.com
Are you over 18 and want to see adult content?
![A complete backup of pthorticulture.com](https://www.archivebay.com/archive2/9d809bfb-e89b-4712-9cb0-de719ae8abd5.png)
A complete backup of pthorticulture.com
Are you over 18 and want to see adult content?
![A complete backup of floridahumanities.org](https://www.archivebay.com/archive2/23fb1283-916f-4348-846e-3eba93711deb.png)
A complete backup of floridahumanities.org
Are you over 18 and want to see adult content?
![A complete backup of stcroixdooryard.com](https://www.archivebay.com/archive2/3736ad17-ecc9-464b-a368-acb25872d0ac.png)
A complete backup of stcroixdooryard.com
Are you over 18 and want to see adult content?
![A complete backup of christinelavin.com](https://www.archivebay.com/archive2/e64ad92e-56d4-4eb8-8a9d-79562d3d3ea2.png)
A complete backup of christinelavin.com
Are you over 18 and want to see adult content?
Text
ABOUT CELLTRION
About Us. A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plansto follow up by
DIATRUST™ COVID-19 AG RAPID TEST Celltrion DiaTrust™ COVID-19 Ag Rapid Test is a rapid test based on lateral flow immunoassay intended for the qualitative detection of nucleocapsid and receptor binding domains (RBDs) from the SARS-CoV-2 spike proteins in human nasopharyngeal swab specimen. Results are for the identification of SARS-CoV-2 nucleocapsid and RBD protein antigen.PERFORMANCE
보도자료 목록; Title Attached file Registration date; 1Q 2021 Earnings Release_Celltrion Inc. 2021.05.12: FY2020, 4Q20 Earning Release_Celltrion Inc. GENERIC CELLTRION PROJECT The global generic market, which takes up two-thirds of the global pharmaceutical market, is expected to reach a total market worth of 833 billion dollars by 2021. In recognition of this potential for market growth, Celltrion created the Global Chemical Development Division to strengthen our position in the global pharmaceuticalmarket.
PIPELINE | CELLTRION Celltrion will continue to blaze new trails and discover new opportunities. Project INN Original Major Indications Status Clinical Info; CT-P39: OmalizumabPRESS RELEASE
2021.02.11. Celltrion Group announces positive top-line efficacy and safety data from global Phase II/III clinical trial of COVID-19 treatment candidate CT-P59. 2021.01.13. Celltrion submits application for Conditional Marketing Authorisation of its COVID-19 treatment candidate CT-P59 to the Korean MFDS. 2020.12.29.SAMPINUTE™
Sampinute™ Analyzer (Immunoassay analyzer) Sampinute™ Analyzer detects specific biomarkers via immunoassay (MESIA; Magnetic Electrochemical Sandwich lmmunoassay) from a small amount of test sample. Sampinute™ Analyzer is intended to be used as an in vitro diagnostic medical device. Please read the user manual thoroughly for correct use and keep it for future reference.DIATRUST™
Celltrion DiaTrust™ COVID-19 IgG/IgM Rapid Test is an in vitro diagnostic test based on an immunochromatographic assay. It is designed for qualitative detection of Immunoglobulin G and Immunoglobulin M antibodies of the novel Coronavirus (COVID-19) in BIO BETTER | CELLTRION Antibody-Drug Conjugate (ADC) is a next-generation technology that effectively removes cancer cells by combining oncology drugs with antibodies that selectively attack cancer cells. Celltrion is currently collaborating with Global Pharm to develop ADC bio betters targeting various tumors. Structure of ADC.JOB INFORMATION
Oversee global clinical trial operations (IND application, patient recruitment, and CRO management) Maintain and improve clinical trial quality (clinical trial provider monitoring, etc.)ABOUT CELLTRION
About Us. A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plansto follow up by
DIATRUST™ COVID-19 AG RAPID TEST Celltrion DiaTrust™ COVID-19 Ag Rapid Test is a rapid test based on lateral flow immunoassay intended for the qualitative detection of nucleocapsid and receptor binding domains (RBDs) from the SARS-CoV-2 spike proteins in human nasopharyngeal swab specimen. Results are for the identification of SARS-CoV-2 nucleocapsid and RBD protein antigen.PERFORMANCE
보도자료 목록; Title Attached file Registration date; 1Q 2021 Earnings Release_Celltrion Inc. 2021.05.12: FY2020, 4Q20 Earning Release_Celltrion Inc. GENERIC CELLTRION PROJECT The global generic market, which takes up two-thirds of the global pharmaceutical market, is expected to reach a total market worth of 833 billion dollars by 2021. In recognition of this potential for market growth, Celltrion created the Global Chemical Development Division to strengthen our position in the global pharmaceuticalmarket.
PIPELINE | CELLTRION Celltrion will continue to blaze new trails and discover new opportunities. Project INN Original Major Indications Status Clinical Info; CT-P39: OmalizumabPRESS RELEASE
2021.02.11. Celltrion Group announces positive top-line efficacy and safety data from global Phase II/III clinical trial of COVID-19 treatment candidate CT-P59. 2021.01.13. Celltrion submits application for Conditional Marketing Authorisation of its COVID-19 treatment candidate CT-P59 to the Korean MFDS. 2020.12.29.SAMPINUTE™
Sampinute™ Analyzer (Immunoassay analyzer) Sampinute™ Analyzer detects specific biomarkers via immunoassay (MESIA; Magnetic Electrochemical Sandwich lmmunoassay) from a small amount of test sample. Sampinute™ Analyzer is intended to be used as an in vitro diagnostic medical device. Please read the user manual thoroughly for correct use and keep it for future reference.DIATRUST™
Celltrion DiaTrust™ COVID-19 IgG/IgM Rapid Test is an in vitro diagnostic test based on an immunochromatographic assay. It is designed for qualitative detection of Immunoglobulin G and Immunoglobulin M antibodies of the novel Coronavirus (COVID-19) in BIO BETTER | CELLTRION Antibody-Drug Conjugate (ADC) is a next-generation technology that effectively removes cancer cells by combining oncology drugs with antibodies that selectively attack cancer cells. Celltrion is currently collaborating with Global Pharm to develop ADC bio betters targeting various tumors. Structure of ADC.JOB INFORMATION
Oversee global clinical trial operations (IND application, patient recruitment, and CRO management) Maintain and improve clinical trial quality (clinical trial provider monitoring, etc.) FINANCIALS | CELLTRION Financials. Accurate and transparent information about our business. home; IR ; Non-consolidated; Consolidated PRODUCTS | CELLTRION Products. Celltrion’s products are available worldwide. home; PRODUCTS ; Bio pharmaceutical PIPELINE | CELLTRION Celltrion will continue to blaze new trails and discover new opportunities. Project INN Original Major Indications Status Clinical Info; CT-P39: Omalizumab GOVERNANCE | CELLTRION KAIST (PH.D.) (Current) Chairman of BOD, Celltrion inc. (Former) Vice President of Product Development, Celltrion inc. (Former) CEO, Celltrion Skincure inc. (Former) General Executive Director, Celltrion Skincure inc. (Former) Representative of Biotechnological Laboratory1, Celltrion inc.
TECHNOLOGY - CELLTRION Coronavirus Disease-19 (COVID-19) is a respiratory illness caused by a strain of oronavirus named “severe acute respiratory syndrome coronavirus2 (SARS-CoV-2)”. Symptoms of COVID-19 varies from coughing and a fever to much severe ones as dyspnea (shortness of breath), and in some cases, severe respiratory infections such as pneumonia. Download.DIGITAL HEALTHCARE
Celltrion aims to develop disease prevention and management solutions for individuals by establishing a platform merged with healthcare data. Celltrion’s Digital Healthcare business focuses on creating a patient-centered environment by using health information from the newest ICT technologies and services. Celltrion works close withGround X
BIO BETTER | CELLTRION Antibody-Drug Conjugate (ADC) is a next-generation technology that effectively removes cancer cells by combining oncology drugs with antibodies that selectively attack cancer cells. Celltrion is currently collaborating with Global Pharm to develop ADC bio betters targeting various tumors. Structure of ADC.NEW FORMULATION
Remsima SC is expected to present a new treatment option for patients who want more convenient SC formulation and those who did not benefit from existing drugs,* as well as medical practitioners who want to administer Infliximab IV for faster action and then change the formulations Later. Dual Formulation Option. Intravenous injection.CHAIRMAN MESSAGE
We are here thanks to the efforts of many. We will remember all those who helped us get where we are today, and continue our efforts to contribute to society, the world, and humankind through our business. Thank you. Jungjin Seo, Honorary Chairman, Celltrion Group. We aspire to build a future of coexistence that promises happiness for all.AUDIT·REVIEW
IR Documents. Information about our key performance indicators. home; IR ; Audit · Review Reports CELLTRIONTRANSLATE THIS PAGE Celltrion. Embrace Life. Global healthcare leader Celltrion will continue. its innovation to promote better and happier lives. forhumanity.
ABOUT CELLTRION
About Us. A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plansto follow up by
CELLTRIONTRANSLATE THIS PAGE Celltrion. Embrace Life. Global healthcare leader Celltrion will continue. its innovation to promote better and happier lives. forhumanity.
DIATRUST™ COVID-19 AG RAPID TEST Celltrion DiaTrust™ COVID-19 Ag Rapid Test is a rapid test based on lateral flow immunoassay intended for the qualitative detection of nucleocapsid and receptor binding domains (RBDs) from the SARS-CoV-2 spike proteins in human nasopharyngeal swab specimen. Results are for the identification of SARS-CoV-2 nucleocapsid and RBD protein antigen.PERFORMANCE
보도자료 목록; Title Attached file Registration date; 1Q 2021 Earnings Release_Celltrion Inc. 2021.05.12: FY2020, 4Q20 Earning Release_Celltrion Inc. GENERIC CELLTRION PROJECT The global generic market, which takes up two-thirds of the global pharmaceutical market, is expected to reach a total market worth of 833 billion dollars by 2021. In recognition of this potential for market growth, Celltrion created the Global Chemical Development Division to strengthen our position in the global pharmaceuticalmarket.
FINANCIALS | CELLTRION Financials. Accurate and transparent information about our business. home; IR ; Non-consolidated; ConsolidatedSAMPINUTE™
Sampinute™ Analyzer (Immunoassay analyzer) Sampinute™ Analyzer detects specific biomarkers via immunoassay (MESIA; Magnetic Electrochemical Sandwich lmmunoassay) from a small amount of test sample. Sampinute™ Analyzer is intended to be used as an in vitro diagnostic medical device. Please read the user manual thoroughly for correct use and keep it for future reference. CELLTRIONTRANSLATE THIS PAGE Celltrion. Embrace Life. 글로벌 헬스케어 리딩기업 셀트리온. 인류의 더 건강하고 행복한 삶을 위한 우리의 도전은 계속됩니다. CELLTRION - 셀트리온 채용사이트TRANSLATE THIS PAGE 채용문의. 셀트리온제약 채용관련 문의드립니다. 서류전형 결과 관련 문의. 21년 상반기 채용관련 질문드립니다. 비밀번호 찾기. 자주묻는 질문. 전형결과 확인. 인재상. 지원서 작성. CELLTRIONTRANSLATE THIS PAGE Celltrion. Embrace Life. Global healthcare leader Celltrion will continue. its innovation to promote better and happier lives. forhumanity.
ABOUT CELLTRION
About Us. A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plansto follow up by
CELLTRIONTRANSLATE THIS PAGE Celltrion. Embrace Life. Global healthcare leader Celltrion will continue. its innovation to promote better and happier lives. forhumanity.
DIATRUST™ COVID-19 AG RAPID TEST Celltrion DiaTrust™ COVID-19 Ag Rapid Test is a rapid test based on lateral flow immunoassay intended for the qualitative detection of nucleocapsid and receptor binding domains (RBDs) from the SARS-CoV-2 spike proteins in human nasopharyngeal swab specimen. Results are for the identification of SARS-CoV-2 nucleocapsid and RBD protein antigen.PERFORMANCE
보도자료 목록; Title Attached file Registration date; 1Q 2021 Earnings Release_Celltrion Inc. 2021.05.12: FY2020, 4Q20 Earning Release_Celltrion Inc. GENERIC CELLTRION PROJECT The global generic market, which takes up two-thirds of the global pharmaceutical market, is expected to reach a total market worth of 833 billion dollars by 2021. In recognition of this potential for market growth, Celltrion created the Global Chemical Development Division to strengthen our position in the global pharmaceuticalmarket.
FINANCIALS | CELLTRION Financials. Accurate and transparent information about our business. home; IR ; Non-consolidated; ConsolidatedSAMPINUTE™
Sampinute™ Analyzer (Immunoassay analyzer) Sampinute™ Analyzer detects specific biomarkers via immunoassay (MESIA; Magnetic Electrochemical Sandwich lmmunoassay) from a small amount of test sample. Sampinute™ Analyzer is intended to be used as an in vitro diagnostic medical device. Please read the user manual thoroughly for correct use and keep it for future reference. CELLTRIONTRANSLATE THIS PAGE Celltrion. Embrace Life. 글로벌 헬스케어 리딩기업 셀트리온. 인류의 더 건강하고 행복한 삶을 위한 우리의 도전은 계속됩니다. CELLTRION - 셀트리온 채용사이트TRANSLATE THIS PAGE 채용문의. 셀트리온제약 채용관련 문의드립니다. 서류전형 결과 관련 문의. 21년 상반기 채용관련 질문드립니다. 비밀번호 찾기. 자주묻는 질문. 전형결과 확인. 인재상. 지원서 작성. CELLTRIONTRANSLATE THIS PAGE Celltrion. Embrace Life. Global healthcare leader Celltrion will continue. its innovation to promote better and happier lives. forhumanity.
FINANCIALS | CELLTRION Financials. Accurate and transparent information about our business. home; IR ; Non-consolidated; ConsolidatedPERFORMANCE
보도자료 목록; Title Attached file Registration date; 1Q 2021 Earnings Release_Celltrion Inc. 2021.05.12: FY2020, 4Q20 Earning Release_Celltrion Inc. PRODUCTS | CELLTRION Products. Celltrion’s products are available worldwide. home; PRODUCTS ; Bio pharmaceutical PIPELINE | CELLTRION Celltrion will continue to blaze new trails and discover new opportunities. Project INN Original Major Indications Status Clinical Info; CT-P39: OmalizumabDIATRUST™
Celltrion DiaTrust™ COVID-19 IgG/IgM Rapid Test is an in vitro diagnostic test based on an immunochromatographic assay. It is designed for qualitative detection of Immunoglobulin G and Immunoglobulin M antibodies of the novel Coronavirus (COVID-19) in GOVERNANCE | CELLTRION KAIST (PH.D.) (Current) Chairman of BOD, Celltrion inc. (Former) Vice President of Product Development, Celltrion inc. (Former) CEO, Celltrion Skincure inc. (Former) General Executive Director, Celltrion Skincure inc. (Former) Representative of Biotechnological Laboratory1, Celltrion inc.
DIGITAL HEALTHCARE
Celltrion aims to develop disease prevention and management solutions for individuals by establishing a platform merged with healthcare data. Celltrion’s Digital Healthcare business focuses on creating a patient-centered environment by using health information from the newest ICT technologies and services. Celltrion works close withGround X
JOB INFORMATION
Oversee global clinical trial operations (IND application, patient recruitment, and CRO management) Maintain and improve clinical trial quality (clinical trial provider monitoring, etc.) CELLTRION - 셀트리온 채용사이트TRANSLATE THIS PAGE 채용문의. 셀트리온제약 채용관련 문의드립니다. 서류전형 결과 관련 문의. 21년 상반기 채용관련 질문드립니다. 비밀번호 찾기. 자주묻는 질문. 전형결과 확인. 인재상. 지원서 작성.ABOUT CELLTRION
About Us. A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plansto follow up by
CELLTRIONTRANSLATE THIS PAGEABOUT USBUSINESSSCIENCEPRODUCTSIRPR Celltrion. Embrace Life. Global healthcare leader Celltrion will continue. its innovation to promote better and happier lives. forhumanity.
DIATRUST™ COVID-19 AG RAPID TEST Celltrion DiaTrust™ COVID-19 Ag Rapid Test is a rapid test based on lateral flow immunoassay intended for the qualitative detection of nucleocapsid and receptor binding domains (RBDs) from the SARS-CoV-2 spike proteins in human nasopharyngeal swab specimen. Results are for the identification of SARS-CoV-2 nucleocapsid and RBD protein antigen. FINANCIALS | CELLTRION Financials. Accurate and transparent information about our business. home; IR ; Non-consolidated; Consolidated GENERIC CELLTRION PROJECT The global generic market, which takes up two-thirds of the global pharmaceutical market, is expected to reach a total market worth of 833 billion dollars by 2021. In recognition of this potential for market growth, Celltrion created the Global Chemical Development Division to strengthen our position in the global pharmaceuticalmarket.
PERFORMANCE
보도자료 목록; Title Attached file Registration date; 1Q 2021 Earnings Release_Celltrion Inc. 2021.05.12: FY2020, 4Q20 Earning Release_Celltrion Inc.DIATRUST™
Celltrion DiaTrust™ COVID-19 IgG/IgM Rapid Test is an in vitro diagnostic test based on an immunochromatographic assay. It is designed for qualitative detection of Immunoglobulin G and Immunoglobulin M antibodies of the novel Coronavirus (COVID-19) inSAMPINUTE™
Sampinute™ Analyzer (Immunoassay analyzer) Sampinute™ Analyzer detects specific biomarkers via immunoassay (MESIA; Magnetic Electrochemical Sandwich lmmunoassay) from a small amount of test sample. Sampinute™ Analyzer is intended to be used as an in vitro diagnostic medical device. Please read the user manual thoroughly for correct use and keep it for future reference.JOB INFORMATION
Oversee global clinical trial operations (IND application, patient recruitment, and CRO management) Maintain and improve clinical trial quality (clinical trial provider monitoring, etc.) CELLTRION - 셀트리온 채용사이트TRANSLATE THIS PAGE 채용문의. 셀트리온제약 채용관련 문의드립니다. 서류전형 결과 관련 문의. 21년 상반기 채용관련 질문드립니다. 비밀번호 찾기. 자주묻는 질문. 전형결과 확인. 인재상. 지원서 작성.ABOUT CELLTRION
About Us. A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plansto follow up by
CELLTRIONTRANSLATE THIS PAGEABOUT USBUSINESSSCIENCEPRODUCTSIRPR Celltrion. Embrace Life. Global healthcare leader Celltrion will continue. its innovation to promote better and happier lives. forhumanity.
DIATRUST™ COVID-19 AG RAPID TEST Celltrion DiaTrust™ COVID-19 Ag Rapid Test is a rapid test based on lateral flow immunoassay intended for the qualitative detection of nucleocapsid and receptor binding domains (RBDs) from the SARS-CoV-2 spike proteins in human nasopharyngeal swab specimen. Results are for the identification of SARS-CoV-2 nucleocapsid and RBD protein antigen. FINANCIALS | CELLTRION Financials. Accurate and transparent information about our business. home; IR ; Non-consolidated; Consolidated GENERIC CELLTRION PROJECT The global generic market, which takes up two-thirds of the global pharmaceutical market, is expected to reach a total market worth of 833 billion dollars by 2021. In recognition of this potential for market growth, Celltrion created the Global Chemical Development Division to strengthen our position in the global pharmaceuticalmarket.
PERFORMANCE
보도자료 목록; Title Attached file Registration date; 1Q 2021 Earnings Release_Celltrion Inc. 2021.05.12: FY2020, 4Q20 Earning Release_Celltrion Inc.DIATRUST™
Celltrion DiaTrust™ COVID-19 IgG/IgM Rapid Test is an in vitro diagnostic test based on an immunochromatographic assay. It is designed for qualitative detection of Immunoglobulin G and Immunoglobulin M antibodies of the novel Coronavirus (COVID-19) inSAMPINUTE™
Sampinute™ Analyzer (Immunoassay analyzer) Sampinute™ Analyzer detects specific biomarkers via immunoassay (MESIA; Magnetic Electrochemical Sandwich lmmunoassay) from a small amount of test sample. Sampinute™ Analyzer is intended to be used as an in vitro diagnostic medical device. Please read the user manual thoroughly for correct use and keep it for future reference.JOB INFORMATION
Oversee global clinical trial operations (IND application, patient recruitment, and CRO management) Maintain and improve clinical trial quality (clinical trial provider monitoring, etc.) CELLTRION - 셀트리온 채용사이트TRANSLATE THIS PAGE 채용문의. 셀트리온제약 채용관련 문의드립니다. 서류전형 결과 관련 문의. 21년 상반기 채용관련 질문드립니다. 비밀번호 찾기. 자주묻는 질문. 전형결과 확인. 인재상. 지원서 작성. CELLTRIONTRANSLATE THIS PAGE Celltrion. Embrace Life. Global healthcare leader Celltrion will continue. its innovation to promote better and happier lives. forhumanity.
PERFORMANCE
보도자료 목록; Title Attached file Registration date; 1Q 2021 Earnings Release_Celltrion Inc. 2021.05.12: FY2020, 4Q20 Earning Release_Celltrion Inc. PRODUCTS | CELLTRION Products. Celltrion’s products are available worldwide. home; PRODUCTS ; Bio pharmaceutical PIPELINE | CELLTRION Celltrion will continue to blaze new trails and discover new opportunities. Project INN Original Major Indications Status Clinical Info; CT-P39: OmalizumabCEO MESSAGE
CEO Message. Celltrion is leading global healthcare into the next chapter. Jungjin Seo, Honorary Chairman, Celltrion Group. 글로벌 헬스케어의 새로운 장을 열어갑니다. Our beginning was humble. We started with a dream. A dream to benefit patients with affordable drugs. While the other Korean pharmaceutical companiesfocused on
DIGITAL HEALTHCARE
Celltrion aims to develop disease prevention and management solutions for individuals by establishing a platform merged with healthcare data. Celltrion’s Digital Healthcare business focuses on creating a patient-centered environment by using health information from the newest ICT technologies and services. Celltrion works close withGround X
CELLTRIONTRANSLATE THIS PAGE Celltrion. Embrace Life. 글로벌 헬스케어 리딩기업 셀트리온. 인류의 더 건강하고 행복한 삶을 위한 우리의 도전은 계속됩니다.INVESTOR INQUIRIES
1. General Statement . Celltrion, Inc. ("we", "us", "our" or "Celltrion") is committed to protecting and respecting your personal data. In the event that you send us any of your personal data, we are committed to collecting, maintaining, and securing personal data about you in accordance with our internal data protection policies and locallaws.
AUDIT·REVIEW
IR Documents. Information about our key performance indicators. home; IR ; Audit · Review Reports CELLTRION - 셀트리온 채용사이트TRANSLATE THIS PAGE 채용문의. 셀트리온제약 채용관련 문의드립니다. 서류전형 결과 관련 문의. 21년 상반기 채용관련 질문드립니다. 비밀번호 찾기. 자주묻는 질문. 전형결과 확인. 인재상. 지원서 작성. 주 메뉴 바로가기 본문 바로가기 하단 바로가기CELLTRION
gnb메뉴보기
ENG
* KOR
* ENG
* CHN
* ABOUT US
* Company
* About Celltrion
* History
* CI
* Leadership
* Chairman Message
* CEO Message
* Responsibility
* Contact Us
* BUSINESS
* Biosimilar
* Autoimmune Disease* Anti-Cancer Drug
* Small molecules
* Generic Celltrion Project* New Medicines
* New Formulation
* Bio Better
* New Drugs
* U-Healthcare
* Vision 2030
* SCIENCE
* R&D
* Research Center
* Fields of Research* R&D STORY
* Pipeline
* Technology
* PRODUCTS
* Products
* Manufacturing
* Quality
* Facilities
* Production Process* IR
* Financials
* IR Documents
* Performance
* Audit·Review
* Governance
* PR
* Notice
* Press Release
* PR Materials
* Video
* Digital Brochures
* Images
* CAREERS
* Talents
* Employment
*
* Recruiting Process* Job Information
* Welfare
* Zoom in Celltrion
Gnb 메뉴 닫기
Pioneering into the
future
Celltrion has shifted the pharmaceutical paradigm with outstanding biopharmaceutical products, Research and Development capabilities, and expertiseLearn more
다음 페이지 이동Embrace Life
Global healthcare leader Celltrion will continue its innovation to promote better and happier livesfor humanity
다음 페이지 이동Biologics
that are more approachable Celltrion's antibody biosimilars provide patients with high-quality yet affordableLearn more
다음 페이지 이동 Pharmaceuticalsreinnovated By venturing into the $833 billion global pharmaceutical market, we are excited to provide affordable healthcare for more patientsaround the world
Learn more
다음 페이지 이동Pioneering into the
future
Celltrion has shifted the pharmaceutical paradigm with outstanding biopharmaceutical products, Research and Development capabilities, and expertiseLearn more
다음 페이지 이동Embrace Life
Global healthcare leader Celltrion will continue its innovation to promote better and happier livesfor humanity
다음 페이지 이동정지
* Legal Notice
* Privacy Policy
* Export and Import Management Policy * Internal Information Control Regulation*
* Contact Us
* Directions
* 인천광역시 연수구아카데미로 23* 032-850-5000
COPYRICHT © 2019 CELLTRION INC. ALL RIGHTS RESERVED.*
*
*
*
Family site __
* Celltrion
* 셀트리온헬스케어* Celltrion Pharm
* 셀트리온스킨큐어 * 셀트리온복지재단Brand site __
* 램시마
* 트룩시마
* 허쥬마
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0